Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
The SHIRPA protocol was proposed as a rapid, comprehensive screening method for qualitatively abnormal phenotypes in the mouse (Rogers et al., Mamm Genome 8, 711, 1997). This screening technique is currently being used to identify mutants induced by N-ethylnitrosourea (ENU) mutagenesis (Brown and No...
Main Authors: | Rafael, J, Nitta, Y, Peters, J, Davies, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it
by: Nora Yucel, et al.
Published: (2020-12-01) -
Myogenic reprogramming of bone marrow derived cells in a W⁴¹Dmd(mdx) deficient mouse model.
by: Stuart Walsh, et al.
Published: (2011-01-01) -
Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD).
by: Matias Mosqueira, et al.
Published: (2013-01-01) -
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients
by: Rachele Rossi, et al.
Published: (2021-07-01) -
Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
by: Derek W. Wang, et al.
Published: (2018-06-01)